Biomaterial Database

Immunogenicity and reactogenicity of a yeast-derived hepatitis B vaccine in Thai school children. 1989

S Lolekha, and P Bowonkiratikachorn, and K Chimabutra

UI	MeSH Term	Description	Entries
D007110	Immunity, Active	Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination.	Active Immune Response,Active Immune Responses,Active Immunities,Active Immunity,Immune Response, Active,Immune Responses, Active,Immunities, Active,Response, Active Immune,Responses, Active Immune
D008297	Male		Males
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D005260	Female		Females
D006509	Hepatitis B	INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.	Hepatitis B Virus Infection
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917	Antibody Formation	The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.	Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013785	Thailand	Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city.	Kingdom of Thailand,Siam
D014761	Viral Hepatitis Vaccines	Any vaccine raised against any virus or viral derivative that causes hepatitis.	Hepatitis, Viral, Vaccines,Hepatitis Vaccines, Viral,Vaccines, Viral Hepatitis
D017325	Hepatitis B Vaccines	Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.	Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B

Related Publications

S Lolekha, and P Bowonkiratikachorn, and K Chimabutra

Reactogenicity and immunogenicity of a new recombinant yeast-derived hepatitis B vaccine.

November 1988, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,

S Lolekha, and P Bowonkiratikachorn, and K Chimabutra

Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine.

January 1987, Postgraduate medical journal,

S Lolekha, and P Bowonkiratikachorn, and K Chimabutra

Immunogenicity, reactogenicity and comparison of two doses of recombinant DNA yeast-derived hepatitis B vaccine in Ethiopian children.

January 1991, Tropical and geographical medicine,

S Lolekha, and P Bowonkiratikachorn, and K Chimabutra

Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children.

April 1988, The New Zealand medical journal,

S Lolekha, and P Bowonkiratikachorn, and K Chimabutra

Immunogenicity and reactogenicity of a combined hepatitis A-hepatitis B vaccine in adolescents.

January 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,